Novartis reported CHF23.78B in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alcon AG ALC:SW 4.26B 44M
Amgen AMGN:US $ 35705M 305M
Artemis Alpha ATS:LN 0 0
AstraZeneca AZN:LN 27146M 1659M
Bayer BAYN:GR € 38061M 1413M
Biogen BIIB:US $ 6277.4M 1.7M
Bristol Myers Squibb BMY:US $ 37107M 343M
Eli Lilly And LLY:US $ 14692M 460.9M
Fresenius FRE:GR € 24634M 1357M
Fresenius Medical Care FME:GR € 11483M 14.2M
Galapagos GLPG:NA 16.88M 1.41M
Genmab GEN:DC 356M 7M
GlaxoSmithKline GSK:LN 18784M 10442M
Hikma Pharmaceutical HIK:LN 1.41B 689M
Lonza Group LONN:SW 1.95B 287M
Merck MRK:GR € 9385M 1099M
Novartis NVS:US $ 23784M 589M
Novartis NOVN:VX SF 23784M 589M
Orion ORNBV:FH 203.3M 116.7M
Philips PHIA:NA € 6788M 312M
Recordati REC:IM 1.45B 46.64M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M